Biogen says death of MS patient not related to Tecfidera

[MSUK]

Biogen Idec Inc. said its new multiple-sclerosis drug, Tecfidera, wasn't to blame for the death earlier this year of a 59-year-old woman who had taken the pill.

In July, the Weston, Mass., biotech company said it was investigating the death of the woman from a form of pneumonia that the company said was common in multiple-sclerosis patients. She had taken Tecfidera for 5½ weeks before vomiting, diarrhea and other side effects prompted her to stop taking the pill, and died 2½ weeks after discontinuing treatment, the company had said. The woman had a history of irritable bowel disease and recurring infections like bronchitis, according to the company...... Read More - http://www.ms-uk.org/BG12